Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elisabeth Kretschmer-Chott

Clinical Outcome of Standardized 177Lu-Psma-617 Therapy in Metastatic Prostate Cancer Patients Receiving 7400 MBq Every 4 Weeks

European Journal of Nuclear Medicine and Molecular Imaging

Nuclear Medicine

English

Related publications

225Ac-Psma-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine

Nuclear Medicine

English

[ 177 Lu]-Psma-617 Radionuclide Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer – Author's Reply

The Lancet Oncology

English

Predictors of Response to Radioligand Therapy of Metastatic Castrate-Resistant Prostate Cancer With 177 Lu-Psma-617

Journal of Nuclear Medicine

Nuclear Medicine

English

Targeted Α-Therapy of Metastatic Castration-Resistant Prostate Cancer With225Ac-Psma-617: Dosimetry Estimate and Empiric Dose Finding

Journal of Nuclear Medicine

Nuclear Medicine

English

Results From Extended Lymphadenectomies With [111In]PSMA-617 for Intraoperative Detection of PSMA-PET/CT-positive Nodal Metastatic Prostate Cancer

EJNMMI Research

Nuclear Medicine

English

A Self-Fulfilling Prophecy: Comparing 177Lu-Psma Radioligand Therapy in Taxane Naïve vs Post-Taxane Metastasized Prostate Cancer Patients?

Journal of Nuclear Medicine

Nuclear Medicine

English

Tumor Uptake in Glioblastoma Multiforme After IV Injection of [177Lu]Lu-Psma-617

European Journal of Nuclear Medicine and Molecular Imaging

Nuclear Medicine

English

Correction To: 225Ac-Psma-617 in Chemotherapy-Naive Patients With Advanced Prostate Cancer: A Pilot Study

European Journal of Nuclear Medicine and Molecular Imaging

Nuclear Medicine

English

Alpha-Pet for Prostate Cancer: Preclinical Investigation Using 149Tb-Psma-617

Scientific Reports

Multidisciplinary

English